In 2021, he joined the Pillar investing team to support companies across a wide range of biotech and deep tech. Outside investing, Tony’s core interest has been to accelerate science through work with FutureHouse, Nucleate, and Homeworld Collective. His investments include Latent Labs, Nabla Bio, Portal Biotech, and Amber Bio, among others.
